NCT01205685 2012-09-11Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerVanderbilt-Ingram Cancer CenterPhase 2 Terminated11 enrolled 9 charts